Selective use of PET scan in the preoperative staging of NSCLC

Lung Cancer

Volumn 21, Issue 3, 1998, Pages 177-184

  Kutlu, Cemal Asim ^a   Pastorino, Ugo ^a   Maisey, Michael ^a   Goldstraw, Peter ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

PET scan; Staging of lung cancer

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BRONCHOSCOPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; IMAGING; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; PRIORITY JOURNAL; TECHNIQUE; THORAX SURGERY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032170447     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(98)00026-9     Document Type: Article

References (31)

1. Webb W.R., Gatsonis C., Zerhoni E.A. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncologic Group. Radiology. 178:1991;705-713.
2. Mattews M.J., Kanhouwa S., Picken J., Robinette D. Frequency of residual and metastatic tumour in patients undergoing curative surgical resection for lung cancer. Cancer Chem Respir. 4:1973;63-67.
3. Gallagher B.M., Fowler J.S., Gutterson N.I.et al. Metabolic trapping as a principal of radiopharmaceutical design: some factors responsible for biodistribution of F-18-2-deoxy-2-fluoro-D-glucose. J Nucl Med. 19:1978;1154-1161.
4. Warburg O. The Metabolism of Tumours. London: Constable, 1930.
5. Fukuda H., Matsuzawa T., Abe Y. Experimental study for lung cancer diagnosis with positron-labelled fluorinated glucose analogous. Eur J Nucl Med. 7:1982;294-297.
6. DiChiro G., Brooks R.A. PET FDG of untreated and treated cerebral gliomas. J Nucl Med. 29:1988;421-422.
7. Alavi J.B., Alavi A., Chawluk J., Kushner M., Powe J., Hickey W.et al. Positron emission tomography in patients with glioma: a predictor of prognosis. Cancer. 62:1988;1074-1078.
8. Dahlbom M., Hoffman E.J., Hoh C.K.et al. Evaluation of a positron emission tomography (PET) scanner for whole body imaging. J Nucl Med. 33:1992;1191-1199.
9. Jabour B.A., Choi Y., Hoh C., Chaiken L., Hawkins R.A., Lufkin R.B.et al. Postradiation tumour recurrence in head and neck: PET FDG detection with pathologic correlation. Radiology. 181:1991;200-205.
10. Kubota R., Matsuzawa T., Amemiya A., Kondo M., Fujiwara T., Watanuki S.et al. Imaging of breast cancer with (18F) fluorodeoxyglucose and positron emission tomography. Comput Assist Tomogr. 13:1989;1097-1098.
11. Strauss L.G., Clorius J.H., Schlag P., Hehner B., Kimming B., Engenhart R.et al. Recurrence of colorectal tumours: PET evaluation. Radiology. 170:1989;329-332.
12. Dewan N.A., Gupta N.C., Redepening I., Phalen J.J., Frick M.P. Diagnostic efficacy of PET FDG imaging in solitary pulmonary nodules. Chest. 104:1993;997-1002.
13. Scott W.J., Schwabe J.L., Gupta N.C., Dewan N.A., Reeb S.D., Sugimoto J.T.et al. Positron emission tomography of lung tumours and mediastinal lymph nodes using 18-F fluorodeoxyglucose. Ann Thorac Surg. 58:1994;698-703.
14. Valk P.E., Pounds T.R., Hopkins D.M., Haseman M.K., Hofer G.A., Greiss H.B.et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg. 60:1995;1573-1582.
15. Pearson F.G. Lung cancer: past twenty-five years. Chest. 4:1986;200-205S.
16. Ichinose Y., Hara N., Ohta M., Motohiro A., Maeda T., Nobe T.et al. Preoperative examination to detect distant metastasis is not advocated for asymptomatic patients with stages 1 and 2 non-small cell lung cancer. Preoperative examination for lung cancer. Chest. 96:1989;1104-1109.
17. McLoud T.C., Bourgouin P.M., Greenberg R.W.et al. Bronchogenic carcinoma: analysis in the mediastinum with CAT by correlative lymph node mapping and sampling. Radiology. 182:1992;319-323.
18. Sanders C. Transthoracic needle aspiration. Clin Chest Med. 13:1992;11-16.
19. Salazar A.M., Wescott J.L. The role of transthoracic needle biopsy for the diagnosis and staging of lung cancer. Clin Chest Med. 14:1993;99-109.
20. Gupta N.C., Frank A.R., Dewan N.A., Redepenning L.S., Rothberg M.L., Mailliard J.A.et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-(F-18)-fluoro-deoxy-D-glucose. Radiology. 184:1992;441-444.
21. Patz E.F., Lowe V.J., Hoffman J.M., Paine S.S., Burrowes P., Coleman R.E.et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology. 188:1993;487-490.
22. Strauss L.G., Conti P.S. The applications of PET in clinical oncology. J Nucl Med. 31:1991;623-648.
23. Duhaylongsod F.G., Lowe V.J., Patz E.F., Vaughn A.L., Coleman R.E., Wolfe W.G. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography. J Thorac Cardiovasc Surg. 110:1995;130-140.
24. Valind S.O., Rhodes C.G., Pantin C. Measurement of pulmonary glucose metabolism in patients with cryptogenic fibrosing alveolitis and pulmonary sarcoidosis (abstract). Am Rev Respir Dis. 129:1984;353.
25. Nolop K.B., Rhodes C.G., Brudin L.H., Beaney M.R., Krausz T., Jones T.et al. Glucose utilization in vivo by human pulmonary neoplasm. Cancer. 60:1987;2682-2689.
26. Haslett C., Clark R.J., Jones H.A.et al. Neutrophil metabolic activity in localised pulmonary inflammation measured non-invasively by positron emission tomography (PET). Physiologist. 32:1989;210-216.
27. Kubota K., Matsuzawa T., Fujiwara T., Hatazawa J., Ito M., Abe K. Comparison of C-11 methionine and F-18-fluorodeoxyglucose for differential diagnosis of lung tumour. J Nucl Med. 30:1989;788-789.
28. Rege S.D., Hoh C.K., Glaspy J.A., Aberle D.R., Dahlbom M., Razavi M.K.et al. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer. 72:1993;82-90.
29. Wahl R.L., Hutchins G.D., Buchsbaum D.J., Liebert M., Grossman H.B., Fisher S. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumour xenografts. Cancer. 67:1991;1544-1550.
30. Patz E.F., Lowe V.J., Hoffman J.M., Paine S.S., Harris L.K., Goodman P.C. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-F-18-2-deoxy-D-glucose. Radiology. 191:1994;379-382.
31. Lillington G.A. Management of solitary pulmonary nodules. Dis Mon. 5:1991;271-318.